Core Muscle Strength in Women with Primary Dysmenorrhoea
NCT ID: NCT06854900
Last Updated: 2025-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2024-01-15
2024-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diaphragmmatic Muscle Strength and Balance in Women With Dysmenorhea
NCT05885945
Sacroiliac Joint Dysfunction and Spinal Mobility in Women With Primary Dysmenorrhoea
NCT06210048
The Effect of Myofascial Release Technique on the Treatment of Primary Dysmenorrhea in Psoas Muscle
NCT04254510
Primary Dysmenorrhea Severity in Athletic vs. Non-Athletic Females
NCT06075654
Investigation of the Effect of Online Yoga Based Exercise Program on Women With Primary Dysmenorrhea
NCT05081869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study found that women with PD had higher muscle activations, lower pelvic tilt angles, and more severe menstrual symptoms. We believe these results may contribute to the etiology of PD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dysmenorrhea
Dysmenorrhea
No interventions assigned to this group
Healthy Woman
Healthy Woman
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Age between 18 and 35 years
Diagnosed with Primary Dysmenorrhea (PD) according to the PD consensus criteria, which include:
Presence of menstrual pain within the first few years after menarche A Visual Analog Scale (VAS) pain score of 4 or higher in the last six months No pelvic pathology Having a regular menstrual cycle (21-35 days) No uterine disorders
Exclusion Criteria
Since our study consists of two groups (participants with and without Primary Dysmenorrhea), the power analysis was conducted using the "Means: Difference between two independent means (two groups)" method.
Based on similar studies, an effect size of d = 0.726 was used for the calculation.
With a statistical power of 80% and a significance level of 5% (α = 0.05), the minimum required sample size was determined to be at least 25 participants per group, totaling 50 participants.Pregnancy or suspicion of pregnancy Active sexual life History of childbirth Use of an intrauterine device (IUD) History of surgery involving the abdomen, spine, or pelvic region within the last year Diagnosis of secondary dysmenorrhea Body mass index (BMI) of 30 or higher
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Derya Azim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Derya Azim
Asst. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Derya
Bandırma, Balıkesir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03. 04. 2024-176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.